1. Catalog
  2. Hepatoxicity SIG (Mar 24): Hepatotoxicity in infla ...
Hepatoxicity SIG (Mar 24): Hepatotoxicity in inflammatory bowel disease: immunomodulators, biologics, and beyond
Image For Activity Cover
Create Account
Availability
On-Demand
Cost
Member: $0.00
Non-Member: $25.00
Patient: $0.00
Associate: $15.00
Student: $0.00
Early Career: $0.00
Industry Rep: $25.00
Credit Offered
No Credit Offered
  • Description
  • Faculty
  • Privacy Policy
  • Recommended
In this presentation, the speaker will review the most common causes of hepatotoxicity in patients with inflammatory bowel disease. The existing literature on clinical phenotypes of injury due to azathioprine/ 6-mercaptopurine, TNF-alpha inhibitors, and anti-integrins will be reviewed and the potential underlying mechanisms will be discussed.

This activity was originally presented on March 14, 2024.

COPYRIGHT: All faculty in this activity have given their permission for publication ©2024 AASLD.

This activity will not offer CE Credit.
Einar Stefán Björnsson, MD, PhD
Powered By